| Seelos Therapeutics Inc (SEEL) | |||
|---|---|---|---|
| 0.9002 -0.1 (-9.97%) | 08-08 16:00 | ||
| Open: | 0.97 | Pre. Close: | 0.9999 |
| High: | 1.04 | Low: | 0.9002 |
| Volume: | 1,218,314 | Market Cap: | 96M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 1.041 - 1.046 | 1.046 - 1.049 |
| Low: | 0.889 - 0.895 | 0.895 - 0.899 |
| Close: | 0.891 - 0.9 | 0.9 - 0.906 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 1.21 One year: 1.42 |
| Support: | Support1: 0.85  Support2: 0.74 |
| Resistance: | Resistance1: 1.04 Resistance2: 1.21 |
| Pivot: | 0.91 |
| Moving Averages: | MA(5): 0.93 MA(20): 0.91 MA(100): 0.75 MA(250): 1.33 |
| MACD: | MACD(12,26): 0.03 Signal(12,26,9): 0.04 |
| %K %D: | %K(14,3): 60.35 %D(3): 53.45 |
| RSI: | RSI(14): 52.78 |
| 52-Week: | High: 2.79 Low: 0.48 Change(%): -55.2 |
| Average Vol(K): | 3-Month: 1193 10-Days: 542 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SEEL ] has closed above bottom band by 46.4%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Capital Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 106.09 |
| Shares Float (M) | 101.32 |
| % Held by Insiders | 4.83 |
| % Held by Institutions | 41.21 |
| Shares Short (K) | 6580 |
| Shares Short Prior Month (K) | 9440 |
| Stock Financials | |
|---|---|
| EPS | -0.609 |
| Book Value (p.s.) | 0.250 |
| Profit Margin | |
| Operating Margin | |
| Return on Assets (ttm) | -64.3 |
| Return on Equity (ttm) | -134.7 |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -66.29 |
| Levered Free Cash Flow (M) | -46.35 |
| Stock Valuation | |
|---|---|
| PE Ratio | -1.48 |
| PEG Ratio | |
| Price to Book value | 3.60 |
| Price to Sales | |
| Price to Cash Flow | -1.44 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
